Baker McKenzie has advised EQT Life Sciences on the successful closing of a EUR 128 million (USD 138.8 million) Series B2 financing of Tubulis. The round was co-led by EQT Life Sciences and Nextech Invest, on behalf of one or more funds managed by it, with participation from new US-based funds, Frazier Life Sciences and […]